IL17A and breast carcinoma: Previous studies have revealed that IL-17 was involved in tumor occurrence, metastasis, angiogenesis, immune-resistance and other processes [26–28], and confirmed that IL-17 signaling pathway also played an important role in the occurrence and progression of GC [29], breast cancer [30] and pancreatic cancer [31].